Insider holders · CIK 0001059784
GENEREX BIOTECHNOLOGY CORP · GNBT
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| John P BarrattDirector | 5,874,162 | — | 5,874,162 | Apr 27, 2015 · 4:00 pm EDT | Form 4 |
| David BrusegardChief Operating Officer | 5,615,070 | — | 5,615,070 | Feb 16, 2016 · 5:03 pm EST | Form 4 |
| Mark FletcherEVP General Counsel &Secretary | 15,625 | — | 15,625 | Oct 15, 2018 · 4:16 pm EDT | Form 4 |
| Harold Gray Hainesrelationship not stated | 945 | — | 945 | Dec 14, 2018 · 2:31 pm EST | Form 4 |
| Brian McGeeDirector | 70 | — | 70 | Oct 15, 2018 · 4:17 pm EDT | Form 4 |
| Andrew RoChief Investment Officer & SVP | 0 | — | 0 | Oct 15, 2018 · 4:14 pm EDT | Form 3 |
| Kevin CentofantiDirector | 0 | — | 0 | Oct 15, 2018 · 4:12 pm EDT | Form 3 |
| Gary Herbert LymanDirector | 0 | — | 0 | Oct 15, 2018 · 4:13 pm EDT | Form 3 |
| Richard David Purcell Jr.SVP Product Launch & Develop | 0 | — | 0 | Oct 15, 2018 · 4:14 pm EDT | Form 3 |
| Mark CorraoCFO & Treasurer | 0 | — | 0 | Oct 15, 2018 · 4:13 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.